Research Article
Identification of SOX6 and SOX12 as Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma: A Retrospective Study Based on TCGA Database
Table 1
Clinical information of clear cell renal cell carcinoma patients in The Cancer Genome Atlas (TCGA) database.
| Clinical features | Variables | Total () | Percentages (%) |
| Age | ≤60 | 264 | 49.81 | >60 | 266 | 50.19 |
| Gender | Female | 186 | 35.09 | Male | 344 | 64.91 |
| Histological grade | G1 | 14 | 2.64 | G2 | 227 | 42.83 | G3 | 206 | 38.87 | G4 | 75 | 14.15 | GX | 5 | 0.94 | Unknown | 3 | 0.57 |
| Clinical stage | Stage I | 265 | 50 | Stage II | 57 | 10.74 | Stage III | 123 | 23.21 | Stage IV | 82 | 15.48 | Unknown | 3 | 0.57 |
| T classification | T1 | 271 | 51.13 | T2 | 69 | 13.02 | T3 | 179 | 33.77 | T4 | 11 | 2.08 |
| Distant metastasis | M0 | 420 | 79.25 | M1 | 78 | 14.72 | MX | 30 | 5.66 | Unknown | 2 | 0.37 |
| Lymph nodes | N0 | 239 | 45.09 | N1 | 16 | 3.02 | NX | 275 | 51.89 |
|
|